Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$914.37 8.99 (0.99%) as of 4:30 Mon 7/1


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 874.67(B)
Last Volume: 2,545,641 Avg Vol: 3,268,697
52 Week Range: $434.7 - $909.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,520,577 2,391,327 3,771,329 6,318,238
Total Sell Value $1,284,658,855 $1,892,909,435 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 18 31 50 93
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1436
  Page 54 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2015-01-28 4 A $70.97 $97,442 D/D 1,373 4,420     -
   Simmons Jeffrey N SVP&Pres. Elanco Animal Health   •       –      –    2015-01-28 4 A $70.97 $1,962,533 D/D 27,653 107,089     -
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2015-01-28 4 A $70.97 $593,948 I/I 8,369 22,578     -
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2015-01-28 4 A $70.97 $889,609 D/D 12,535 39,028     -
   Ricks David A SVP and Pres, Lilly Bio-Meds   •       –      –    2015-01-28 4 A $70.97 $1,933,791 D/D 27,248 61,403     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2015-01-28 4 A $70.97 $83,319 I/I 1,174 8,984     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2015-01-28 4 A $70.97 $1,936,558 D/D 27,287 80,817     -
   Peterson Barton R Sr. VP, Corp. Affairs & Comm.   •       –      –    2015-01-28 4 A $70.97 $1,139,139 D/D 16,051 75,700     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2015-01-28 4 A $70.97 $7,618,204 D/D 107,344 634,622     -
   Lundberg Jan M EVP,Science&Tech and Pres. LRL   •       –      –    2015-01-28 4 A $70.97 $3,127,861 D/D 44,073 199,131     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2015-01-28 4 A $70.97 $1,472,840 D/D 20,753 57,798     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2015-01-28 4 A $70.97 $1,338,139 D/D 18,855 63,163     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2015-01-28 4 A $70.97 $2,131,726 D/D 30,037 104,400     -
   Alvarez Ralph Director   –       •      –    2014-12-31 4 A $69.67 $8,569 D/D 123 26,574     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2014-12-10 4/A D $72.21 $395,278 D/D (5,474) 74,363     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2014-12-10 4 D $72.21 $436,582 D/D (6,046) 73,791     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2014-12-10 4 OE $55.65 $395,171 D/D 7,101 79,837     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2014-12-04 5 GD $0.00 $0 D/D 730 86,757     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2014-12-04 5 GD $0.00 $0 D/D 393 527,278     -
   Lilly Endowment Inc 10% Owner   –       –       •   2014-12-04 4 S $71.92 $13,664,800 D/D (190,000) 131,405,804     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2014-12-03 5 GD $0.00 $0 D/D 1,179 527,671     -
   Lilly Endowment Inc 10% Owner   –       –       •   2014-12-02 4 S $70.03 $12,624,395 D/D (180,000) 131,595,804     -
   Marram Ellen R Director   –       •      –    2014-11-28 4 A $67.29 $145,010 D/D 2,155 42,728     -
   Tai Jackson P Director   –       •      –    2014-11-28 4 A $67.29 $145,010 D/D 2,155 34,464     -
   Eskew Michael L Director   –       •      –    2014-11-28 4 A $67.29 $145,010 D/D 2,155 28,593     -
  1436 Records found
  Previous  50  51  52  53  54  55  56  57  58   
  Page 54 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us